|
|
CASE REPORT |
|
Year : 2014 | Volume
: 20
| Issue : 2 | Page : 86-88 |
|
Jugular foramen chondrosarcoma
Vinay Vaidyanathan1, Deepa Nair2, SL Juvekar3, Caren D'Souza4
1 Department of ENT, Father Muller Medical College, Mangalore, Karnataka, India 2 Department of Head and Neck Surgical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India 3 Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India 4 Department of Surgery, Father Muller Medical College, Mangalore, Karnataka, India
Date of Web Publication | 3-May-2014 |
Correspondence Address: Vinay Vaidyanathan Department of ENT, Father Muller Medical College, Mangalore, Karnataka India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0971-7749.131876
Chondrosarcomas are rare skull base lesions and presenting as a mass lesion in the jugular foramen is even rarer. The clinical picture and series of scans unfolded its diverse presentation on imaging making its diagnosis very interesting. Preoperative finding and final histopathological picture were diagnostic.
Keywords: Chondrosarcoma, Computerized tomography angiography, Computerized tomography scan, Jugular foramen, Magnetic resonance imaging scan
How to cite this article: Vaidyanathan V, Nair D, Juvekar S L, D'Souza C. Jugular foramen chondrosarcoma
. Indian J Otol 2014;20:86-8 |
Introduction | |  |
A 42-year-old perimenopausal female presented with complaints of insidious onset right sided facial weakness, tinnitus and decreased hearing of 2 months duration. There was no recent history of upper respiratory tract infection or aural infection or trauma. No history of vertigo. On examination, she had Grade I to II right sided motor facial palsy. Sensory and secretomotor divisions were intact and minimal right hypoglossal nerve paresis seen. All other cranial nerves were normal. Otoscopic examination was unremarkable. Tuning fork test was suggestive of right sided sensorineural hearing loss (SNHL). Pure tone audiometry showed moderate to severe SNHL in right ear. Impedance audiometry and stapedial reflex for both ipsi and contra lateral ears were normal. Vestibular system examination was normal. Tinnitus was subjective in nature. Computerized tomography (CT) scan and magnetic resonance imaging (MRI) scan was performed [Figure 1] and [Figure 2]. | Figure 2: T2-Weighted magnetic resonance imaging showing heterogeneous mass
Click here to view |
Computerized tomography picture [Figure 1] demonstrated permeative erosion of the jugular foramen (JF) with popcorn calcification. MRI picture [Figure 2] demonstrated an ill-defined lobulated extra axial lesion, appearing heterogeneously hyper intense on T2-Weighted images and showing heterogeneous postcontrast enhancement, in the right JF region. The internal jugular vein (IJV) is not visualized in the region of JF and beyond. Right sigmoid sinus was not visualized proximally. The lesion was present medially in the hypotympanum, extending posteriorly into the mastoid, abutting sigmoid sinus and medially abutting the hypoglossal canal and showed patchy post contrast enhancement. CT angiography [Figure 3] showed minimal contrast enhancement in all phases of angiogram, and the jugular bulb was completely occluded with disease abutting the hypoglossal nerve.
With a provisional diagnosis of chondrogenic tumor, the patient was taken up for surgery. A C-shaped postauricular incision was taken 2 cm posterior and parallel to the groove and extended it into the neck. Upper part of the neck dissected and mobilized nerve monitors were used intraoperatively. A 2 × 2 cm bony lesion was excised from the region of JF, which was pressing on the facial nerve trunk near the stylomastoid foramen but, was free from the adjacent structures. IJV was well preserved, facial nerve was dissected free of the tumor and all other lower cranial nerves were identified and preserved [Figure 4]. | Figure 4: Styloid apparatus is displaced inferiorly, mastoid cortex and tip is removed to expose the tumor. Intraparotid division of facial nerve is seen anteriorly
Click here to view |
Histopathology was reported as chondrosarcoma (CSA) Grade II.
Immunohistochemistry-stained positive for S-100 protein and vimentin.
Discussion | |  |
Chondrosarcoma of the skull is rare slow growing locally aggressive malignant tumors that constitute 0.15% of all intracranial neoplasms, three-fourths of which occur at the cranial base, accounting for 6% of all neoplasms at this site. The JF is an exceptionally rare location for CSAs though middle cranial fossa is the most common site in skull base. [1] JF region is a complex anatomical area that is an important though relatively uncommon location for skull base tumors. Pathology in the JF may manifest with dysfunction of only the traversing cranial nerves (CN IX, X, XI) and very rarely adjacent XII CN. [2]
In a retrospective study, they found that the common symptoms of dysphonia and dysphagia were because of lower cranial nerve compression. [1] Aural tinnitus and hearing loss are a common presentation in other more common JF lesions like meningioma and glomus jugulare. Facial nerve involvement is an uncommon feature of CSA or any other JF lesion as the nerve trunk is not a close anatomical relation to JF. Sanna et al. [1] who has the largest published series of five cases of JF CSA did not find VII CN involvement in any of his cases; this was rather an atypical finding which was attributed to the lesion compressing on the facial nerve trunk near the stylomastoid foramen as it exited the temporal bone.
Computerized tomography and MRI are the most logical tools of investigation whose benefits have been well reviewed. CSA on MRI would show high signal intensity on T2-Weighted images and slight enhancement with gadolinium unlike glomus jugulare, which shows classical salt and pepper appearance with intense enhancement with gadolinium. Most of the JF space occupying lesions will show erosive enlargement of JF not providing much information on differentiating features. [3]
Contrast enhanced MRI or angiography serves as an unparallel diagnostic tool for such clinical dilemmas. On angiography, classical tumor blush is seen in glomus and a contrast picture of an avascular mass in CSA. [4]
Histopathologically, CSAs are divided into the following subtypes: Conventional (myxoid and hyaline types), dedifferentiated, clear cell, and mesenchymal with the conventional form being the most common type within the skull base. Dedifferentiated and mesenchymal CSA variants are more aggressive and may metastasize, but account for <10% of all skull base CSAs. Rosenberg et al. further subdivided the conventional type into three grades based on cellularity, nuclear size of the cells, chondroid matrix, and nuclear atypia: well differentiated (Grade I), moderately differentiated (Grade II), and poorly differentiated (Grade III). Conventional type Grade I variety is most common followed by Grade II. CSA of the skull base is frequently misdiagnosed histologically as chordoma, especially the chondroid variety of chordoma. Immunohistochemical analysis is particularly helpful to differentiate chordomas from CSAs. Chordomas stain positively for epithelial membrane antigen, cytokeratin, vimentin, and S-100 protein. In contrast, CSAs stain positively only for S-100 protein and vimentin. [5] Surgical excision is the treatment of choice for chondroid tumors of skull base.
References | |  |
1. | Sanna M, Bacciu A, Pasanisi E, Piazza P, Fois P, Falcioni M. Chondrosarcomas of the jugular foramen. Laryngoscope 2008;118:1719-28.  |
2. | Kryzanski JT, Heilman CB. Clinicopathologic features of jugular foramen tumors. Oper Tech Neurosurg 2005;8:6-12.  |
3. | Katoh M, Tada M, Sawamura Y, Abe H. Total removal of huge chondrosarcoma of the skull base with facial nerve resection and reconstruction. J Clin Neurosci 1998;5:342-5.  |
4. | Ong CK, and Fook-Hin CV. Imaging of jugular foramen. Neuroimaging Clinics of North America,2009; 19:469-82.  |
5. | Rosenberg AE, Nielsen GP, Keel SB, Renard LG, Fitzek MM, Munzenrider JE, et al. Chondrosarcoma of the base of the skull: A Clinicopathologic study of 200 cases with emphasis on its distinction from Chordoma. American Journal of Surgical Pathology, Nov 1999;23:1370.  |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
|